PNGAF (The Precision Peptide Co) Loans Receivable: $0.00 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PNGAF The Precision Peptide Co Inc PNGAF
22 GF Score
Price $0.34
! 5 Warning Signs
View Full Analysis

What is The Precision Peptide Co Loans Receivable?

The Precision Peptide Co PNGAF -0.89% 22 Loans Receivable is $0.00 Mil as of Apr. 2026. GuruFocus rates PNGAF with a GF Score™ of 22/100. The stock has 5 warning signs investors should review.

The Precision Peptide Co's Loans Receivable for the quarter that ended in Apr. 2026 was $0.00 Mil.

The Precision Peptide Co Loans Receivable Related Terms

The Precision Peptide Co Loans Receivable Historical Data

* Premium members only.

The historical data trend for The Precision Peptide Co's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Precision Peptide Co Loans Receivable Chart

The Precision Peptide Co Annual Data
Trend Oct21 Oct22 Oct23 Oct24 Oct25
Loans Receivable
0.00 0.00 0.00 0.00 0.00

The Precision Peptide Co Quarterly Data
Jul21 Oct21 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
PNGAF
22GF Score
The Precision Peptide Co Inc PNGAF
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Precision Peptide Co Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of $0.00 Mil mean?
The Precision Peptide Co (PNGAF) has a Loans Receivable of $0.00 Mil as of Apr. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on The Precision Peptide Co and its competitors.
Is The Precision Peptide Co's Loans Receivable too high?
The Precision Peptide Co's current Loans Receivable is $0.00 Mil. Overall, The Precision Peptide Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does The Precision Peptide Co's Loans Receivable compare to KHC and GIS?
The Precision Peptide Co's Loans Receivable of $0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Consumer Packaged Goods company?
A good Loans Receivable depends on the Consumer Packaged Goods industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on The Precision Peptide Co and its competitors. The Precision Peptide Co's current Loans Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Precision Peptide Co stock overvalued right now?
The Precision Peptide Co (PNGAF) has a current Loans Receivable of $0.00 Mil. The current Loans Receivable is $0.00 Mil. The Precision Peptide Co's overall GF Score™ is 22/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For The Precision Peptide Co (PNGAF), the current Loans Receivable is $0.00 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Precision Peptide Co Business Description

Other Exchanges XU0:GermanyBPC:Canada
Address 130th Street, Suite 8035, Surrey, BC, CAN, V3W 0H7
The Precision Peptide Co Inc is a food manufacturer and distributor of nutritional supplements, functional snacks, natural foods, peptides, and natural personal care products. The company offers end-to-end services from formulation and ingredient sourcing to final packaging and fulfillment. The Company has two reportable operating segments: the manufacturing and distribution of food products in Canada and the sale and delivery of its peptide products in the United States.
22GF Score

Get the complete analysis for PNGAF

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.34
Price